SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002443
Filing Date
2023-11-14
Accepted
2023-11-14 07:45:27
Documents
53
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcli-20230930x10q.htm   iXBRL 10-Q 1073996
2 EX-31.1 bcli-20230930xex31d1.htm EX-31.1 10077
3 EX-31.2 bcli-20230930xex31d2.htm EX-31.2 10064
4 EX-31.3 bcli-20230930xex31d3.htm EX-31.3 10872
5 EX-32.1 bcli-20230930xex32d1.htm EX-32.1 6440
6 EX-32.2 bcli-20230930xex32d2.htm EX-32.2 8026
7 EX-32.3 bcli-20230930xex32d3.htm EX-32.3 8054
  Complete submission text file 0001410578-23-002443.txt   3781094

Data Files

Seq Description Document Type Size
8 EX-101.SCH bcli-20230930.xsd EX-101.SCH 27845
9 EX-101.CAL bcli-20230930_cal.xml EX-101.CAL 28703
10 EX-101.DEF bcli-20230930_def.xml EX-101.DEF 104821
11 EX-101.LAB bcli-20230930_lab.xml EX-101.LAB 229816
12 EX-101.PRE bcli-20230930_pre.xml EX-101.PRE 187825
47 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20230930x10q_htm.xml XML 450340
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 231401616
SIC: 2836 Biological Products, (No Diagnostic Substances)